Evaluation of VeriStrat, a serum proteomic test, in the randomized, open-label, Phase 3 LUX-Lung 8 trial of afatinib versus erlotinib for the second-line treatment of advanced squamous cell carcinoma of the lung
Articles > Article · 2016
Authors: G. Goss, K.H. Lee, E. Felip, M. Cobo, K. Syrigos, Erdem GÖKER, V. Georgioulias, S.Z. Guclu, D. Isla, Y.J. Min, A. Morabito, N. Dupuis, V.K. Chand, F. Solca, N. Krämer, N. Gibson, E. Ehrnrooth, J.C. Soria
Annals of Oncology, International, WoS, 2016, vol 27, pp vi428-vi428